Couldn't load this record
Something went wrong loading this record — please try again.
Patent Application
Provisional
Small
App. No. 62/704,091
· Confirmation No. 8862
Nasal Delivery of Small Molecules and Oral Hydroxychloroquin to Inhibit Breathing Problems and Infection in COVID-19 Patients
Inventor:
Kalipada PAHAN
Applicant:
Rush University Medical Center
Provisional Application Expired
No downloadable documents found — record may not be publicly available.
Inventors
Kalipada PAHAN
Skokie, IL
Attorneys & Agents of Record
Prosecution
- Customer No.
- 23644
- Docket No.
- 42960-319935
- Confirmation No.
- 8862
Child
Claims priority from a provisional application
→
App. 17/131,265
Filed 2020-12-22
· Abandoned -- Incomplete Application (Pre-examination)
Child
Claims priority from a provisional application
→
App. 17/699,792
· US 11,667,678
Filed 2022-03-21
· Patented Case
Child
PCT
Claims priority from a provisional application
→
PCT/US2021/028369
Filed 2021-04-21
· PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
Child
Claims priority from a provisional application
→
App. 17/133,035
· US 11,339,190
Filed 2020-12-23
· Patented Case
from
PAHAN, KALIPADA
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2022-04-08
from
PAHAN, KALIPADA
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-05-12
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/704,091
- Filed
- 2020-04-21
External Links